QQ客服 官方微博 反馈留言

	Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome
	Pang, H.; Zhang, C.; Liu, F.; Gong, X.; Jin, X.; Su, C.
刊名	MEDICINA INTENSIVA
	2017
卷号	41页码:475-482
关键词	Acute coronary syndrome Thrombin activatable fibrinolysis inhibitor Proinflammatory cytokine Acute phase protein Coronary disease
ISSN号	0210-5691
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3313097
专题	大连理工大学
作者单位	1.Dalian Univ Technol, Dept Biomed Engn, 2 Ling Gong Rd, Dalian 116024, Peoples R China. 2.Jinzhou Med Univ, Affiliated Hosp 1, Vasculocardiol Dept, 2 St 5, Jinzhou City 121000, Peoples R China. 3.Liaoning MEDI Biol Co, Technol Ctr, 166 Xianghuai Rd, Benxi City 117004, Peoples R China.
推荐引用方式 GB/T 7714	Pang, H.,Zhang, C.,Liu, F.,et al. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome[J]. MEDICINA INTENSIVA,2017,41:475-482.
APA	Pang, H.,Zhang, C.,Liu, F.,Gong, X.,Jin, X.,&Su, C..(2017).Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome.MEDICINA INTENSIVA,41,475-482.
MLA	Pang, H.,et al."Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome".MEDICINA INTENSIVA 41(2017):475-482.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。